Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network

Substance Use Clinical Trial

Official title:

Integration of Internet-facilitated Screening, Brief Intervention, Referral to Treatment (iSBIRT) for Teen Drug Use Into a Pediatric Network

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01454206
• Other study ID #: CeASAR app RFADA12008
• Status: Withdrawn
• Phase: Phase 2/Phase 3
• First received: October 5, 2011
• Last updated: October 6, 2016
• Start date: July 2012
• Est. completion date: December 2016

Study information

• Verified date: October 2016
• Source: Boston Children’s Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The Goal of this project is to integrate a previously-tested internet-facilitated Screening, Brief Intervention, and Referral to Treatment (iSBIRT) system for adolescent substance use into a large network of primary care offices, the Pediatric Practices of Children's Hospital Boston (PPOC).

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2016
• Est. primary completion date: October 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 12 Years to 18 Years

Eligibility

Inclusion Criteria:

• 12-18 year olds

• Coming for non-emergent care

• Access to a private computer

• Have email address

Exclusion Criteria:

• Not available for follow-up questionnaires

• Unable to read or understand English at a 6th grade reading level

• Medically or emotionally unstable on the day of the visit

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Substance Use

Intervention

Behavioral:
• iSBIRT
Participants will be screened for substance use, view information about the health effects of substance use on the computer, and receive advice from the primary care provider regarding the health effects of substance use. Those found to be at "high risk" will complete an internet-based program encouraging them to change their substance use.

Locations

Country	Name	City	State
United States	Children's Hospital Boston	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Boston Children’s Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Provider attitude toward iSBIRT	We will evaluate providers' acceptance of and attitude toward integrating iSBIRT into their practices.	12 months post baseline	No
Secondary	Youth connectedness to provider	We will measure adolescents' attitudes toward their providers' advice regarding the health effects of substance use given during the visit	Baseline	No
Secondary	iSBIRT sustainability	We will measure rates of continued use of iSBIRT by practices 12 months after iSBIRT recruitment and implementation ends	12 months post	No
Secondary	Change in rates of adolescent substance use	We will measure the change in rates of adolescent substance use from baseline to 3 months post study visit.	3 months post baseline	No
Secondary	Change in rates of adolescent substance use	We will measure the change in rates of adolescent substance use from baseline to 6 months post study visit.	6 months post baseline	No
Secondary	Change in rates of adolescent substance use	We will measure the change in rates of adolescent substance use from baseline to 12 months post study visit.	12 months post baseline	No

External Links

•   Center for Adolescent Substance Abuse Research at Children's Hospital Boston